Compounds and compositions for treating conditions associated with NLRP activity
Shomir Ghosh, Brookline, MA (US); Jason Katz, Newton, MA (US); William Roush, Boston, MA (US); Hans Martin Seidel, Concord, MA (US); Dong-Ming Shen, Edison, NJ (US); and Shankar Venkatraman, Lansdale, PA (US)
Assigned to Novartis AG, Basel (CH)
Appl. No. 17/292,891
Filed by Novartis AG, Basel (CH)
PCT Filed Nov. 11, 2019, PCT No. PCT/US2019/060772 § 371(c)(1), (2) Date May 11, 2021, PCT Pub. No. WO2020/102098, PCT Pub. Date May 22, 2020.
Claims priority of provisional application 62/760,195, filed on Nov. 13, 2018.
Claims priority of provisional application 62/760,244, filed on Nov. 13, 2018.
Claims priority of provisional application 62/760,248, filed on Nov. 13, 2018.
Prior Publication US 2023/0025630 A1, Jan. 26, 2023
